                         SEQUENCE LISTING

<110>  Unilever PLC
 
<120>  An antimicrobial composition for selectively inhibiting growth of
        P. acnes bacteria

<130>  J2323

<160>  2     

<170>  PatentIn version 3.5

<210>  1
<211>  893
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Nucleotide sequence of endolysin

<400>  1
atgcgttata ttccggcagc acatcattca gcaggtagca atcatccggt taatcgtgtt       60

gttattcatg caacctgtcc ggatgttggt tttccgagcg caagccgtaa aggtcgtgca      120

gttagcaccg caaactattt tgcaagcccg agcagcggtg gtagcgcaca ttatgtttgt      180

gatattggtg aaaccgttca gtgtctgagc gaaggcacca ttggttggca tgcaccgcct      240

aatccgcata gcctgggtat tgaaatttgt gcagatggtg gtagccatgc aagctttcgt      300

gttccgggtc atgcatatac ccgtgaacag tggctggatc cgcgtgtttg gcctgcagtt      360

gaaaaagcag caattctgtg tcgtcgtctg tgcgataaat acaatgttcc gaaacgtaaa      420

ctgagcgcag cagatctgaa agcaggtcgt cgtggtgttt gtggtcatgt tgatgttacc      480

gatgcatggc atcagagcga tcatgatgat ccgggtccgt ggtttccgtg ggatcgtttt      540

atggcagttg ttaatggtca taacgaaagc ggtgaactga ccgttgcaga tgttaaagca      600

ctgcatgatc agattaaaca gctgagcgca cagctggcag gtagcgttaa taaactgcat      660

catgatgttg gtgttgttca ggttcagaat ggtgatctgg gtaaacgtgt tgatgcactg      720

agctgggtta aaaatccggt taccggtaaa ctgtggcgta ccaaagatgc actgtggtca      780

gtttggtatt atgttctgga atgtcgtagc cgtattgatc gtctggaaag cgcagttaat      840

ggtctgaaaa aactcgagca ccaccaccac caccactgag atccggctgc taa             893


<210>  2
<211>  292
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Polypeptide sequence of Endolysin with C-terminal Histidine tag 
       (x6)

<400>  2

Met Arg Tyr Ile Pro Ala Ala His His Ser Ala Gly Ser Asn His Pro 
1               5                   10                  15      


Val Asn Arg Val Val Ile His Ala Thr Cys Pro Asp Val Gly Phe Pro 
            20                  25                  30          


Ser Ala Ser Arg Lys Gly Arg Ala Val Ser Thr Ala Asn Tyr Phe Ala 
        35                  40                  45              


Ser Pro Ser Ser Gly Gly Ser Ala His Tyr Val Cys Asp Ile Gly Glu 
    50                  55                  60                  


Thr Val Gln Cys Leu Ser Glu Gly Thr Ile Gly Trp His Ala Pro Pro 
65                  70                  75                  80  


Asn Pro His Ser Leu Gly Ile Glu Ile Cys Ala Asp Gly Gly Ser His 
                85                  90                  95      


Ala Ser Phe Arg Val Pro Gly His Ala Tyr Thr Arg Glu Gln Trp Leu 
            100                 105                 110         


Asp Pro Arg Val Trp Pro Ala Val Glu Lys Ala Ala Ile Leu Cys Arg 
        115                 120                 125             


Arg Leu Cys Asp Lys Tyr Asn Val Pro Lys Arg Lys Leu Ser Ala Ala 
    130                 135                 140                 


Asp Leu Lys Ala Gly Arg Arg Gly Val Cys Gly His Val Asp Val Thr 
145                 150                 155                 160 


Asp Ala Trp His Gln Ser Asp His Asp Asp Pro Gly Pro Trp Phe Pro 
                165                 170                 175     


Trp Asp Arg Phe Met Ala Val Val Asn Gly His Asn Glu Ser Gly Glu 
            180                 185                 190         


Leu Thr Val Ala Asp Val Lys Ala Leu His Asp Gln Ile Lys Gln Leu 
        195                 200                 205             


Ser Ala Gln Leu Ala Gly Ser Val Asn Lys Leu His His Asp Val Gly 
    210                 215                 220                 


Val Val Gln Val Gln Asn Gly Asp Leu Gly Lys Arg Val Asp Ala Leu 
225                 230                 235                 240 


Ser Trp Val Lys Asn Pro Val Thr Gly Lys Leu Trp Arg Thr Lys Asp 
                245                 250                 255     


Ala Leu Trp Ser Val Trp Tyr Tyr Val Leu Glu Cys Arg Ser Arg Ile 
            260                 265                 270         


Asp Arg Leu Glu Ser Ala Val Asn Gly Leu Lys Lys Leu Glu His His 
        275                 280                 285             


His His His His 
    290         


